Recent studies showed altered MAMs in parkin-silenced SH-SY5Y cells [16], and endoplasmic reticulum–mitochondria interface perturbation in fibroblasts from Parkin (PARK2) knock-out mice, and from PD patients harboring PARK2 mutations [14]. This evidence concerns the gene PRKN and Parkinson disease.